The effect of Rosa damascena mill on menopausal symptoms

Phase 3

• Conditions: menopausal symptoms.; Any condition of the genital system affecting females, caused by pathological changes associated with the perimenopausal period, such as the permanent cessation of menstruation and infertility. Includes: Symptoms such as flushing, sleeplessness, headache,; GA30.00

• Registration Number: IRCT20210208050295N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 78

Inclusion Criteria

Having a minimum education in primary school
Age 45 to 65 years old
Having a normal menopause (stopping menstruation for at least one year after 45 years old, without interfering with pregnancy and lactation, surgery, medication and pathology)
Married and living with her husband
Having sexual intercourse in the last month
Obtained at least 5 score from the initial MRS
Lack of known and treated medical diseases which affect the results of the study (cardiovascular, liver, kidney, chronic lung disorders, thyroid, neurology and psychiatry diseases, musculoskeletal, pelvic prolapse, urinary disorders and neurological diseases known and treated )
No history of cancer

Exclusion Criteria

Drug addiction, smoking and alcohol abuse
Taken medicine that improve menopausal symptoms in the last 6 months (Such as estrogen and progesterone, GnRH agonists and antagonists, clonidine, gabapentin, serotonin and norepinephrine inhibitors, paroxetine, venlafaxine, vitamin E, methyldopa, naloxone and tibolone)
Use of complementary medicine to improve menopausal symptoms (such as herbs, acupuncture and acupressure) during the last 6 months
Women professional athletes or women with severe mobility limitations who are unable to do housework

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of menopause symptoms. Timepoint: At the beginning of the study (before the start of the study) and at the beginning of weeks 4 and 8 after the start of the study. Method of measurement: Menopause raring scale.

Secondary Outcome Measures

Name	Time	Method
Depression, anxiety and stress in menopausal women. Timepoint: At the beginning of the study (before the start of the study) and at the beginning of weeks 4 and 8 after the start of the study. Method of measurement: Depression, Anxiety and Stress Scale.;Quality of sleep in menopausal women. Timepoint: At the beginning of the study (before the start of the study) and at the beginning of weeks 4 and 8 after the start of the study. Method of measurement: Pittsburgh Sleep Quality Index.;Sexual function in menopausal women. Timepoint: At the beginning of the study (before the start of the study) and at the beginning of weeks 4 and 8 after the start of the study. Method of measurement: Female sexual function index.